243 related articles for article (PubMed ID: 21402722)
1. Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.
Tadokoro S; Okamura N; Sekine Y; Kanahara N; Hashimoto K; Iyo M
Schizophr Bull; 2012 Sep; 38(5):1012-20. PubMed ID: 21402722
[TBL] [Abstract][Full Text] [Related]
2. Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.
Varela FA; Der-Ghazarian T; Lee RJ; Charntikov S; Crawford CA; McDougall SA
J Psychopharmacol; 2014 Apr; 28(4):376-86. PubMed ID: 24045880
[TBL] [Abstract][Full Text] [Related]
3. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis.
Oda Y; Tadokoro S; Takase M; Kanahara N; Watanabe H; Shirayama Y; Hashimoto K; Iyo M
J Psychopharmacol; 2015 Dec; 29(12):1308-13. PubMed ID: 26174132
[TBL] [Abstract][Full Text] [Related]
5. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
6. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
Oshibuchi H; Inada K; Sugawara H; Ishigooka J
Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment.
Zhang Y; Xu H; He J; Yan B; Jiang W; Li X; Li XM
Neurosci Lett; 2007 Jun; 420(1):66-71. PubMed ID: 17466452
[TBL] [Abstract][Full Text] [Related]
9. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
El Hage C; Bédard AM; Samaha AN
Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
[TBL] [Abstract][Full Text] [Related]
11. Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
De Carolis L; Schepisi C; Milella MS; Nencini P
Psychopharmacology (Berl); 2011 Dec; 218(4):749-59. PubMed ID: 21660444
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats.
Servonnet A; Allain F; Gravel-Chouinard A; Hernandez G; Bourdeau Caporuscio C; Legrix M; Lévesque D; Rompré PP; Samaha AN
Neuropharmacology; 2021 Oct; 197():108747. PubMed ID: 34364897
[TBL] [Abstract][Full Text] [Related]
13. Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.
Bédard AM; Maheux J; Lévesque D; Samaha AN
Schizophr Bull; 2013 May; 39(3):692-702. PubMed ID: 22927669
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
Inoue A; Miki S; Seto M; Kikuchi T; Morita S; Ueda H; Misu Y; Nakata Y
Eur J Pharmacol; 1997 Feb; 321(1):105-11. PubMed ID: 9083792
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
[TBL] [Abstract][Full Text] [Related]
16. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
17. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-induced oxidative stress in rat brain.
Martins MR; Petronilho FC; Gomes KM; Dal-Pizzol F; Streck EL; Quevedo J
Neurotox Res; 2008 Jan; 13(1):63-9. PubMed ID: 18367441
[TBL] [Abstract][Full Text] [Related]
19. Haloperidol and aripiprazole impact on the BDNF and glucocorticoid receptor levels in the rat hippocampus and prefrontal cortex: effect of the chronic mild stress.
Osacka J; Koprdova R; Tillinger A; Pirnik Z; Kiss A
Endocr Regul; 2021 Sep; 55(3):153-162. PubMed ID: 34523299
[No Abstract] [Full Text] [Related]
20. Upregulation of heat-shock protein HSP-70 and glutamate transporter-1/glutamine synthetase in the striatum and hippocampus in haloperidol-induced dopamine-supersensitivity-state rats.
Kimura M; Oda Y; Hirose Y; Kimura H; Yoshino K; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Pharmacol Biochem Behav; 2021 Dec; 211():173288. PubMed ID: 34653399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]